At QCL Lifescience, our Pulmo Care Division is committed to advancing respiratory health through a focused range of high-quality, affordable, and patient-centric therapies. We cater to individuals suffering from asthma, bronchitis, COPD, allergic rhinitis, and other chronic respiratory conditions with clinically effective and accessible solutions.
🔹 Antihistamine and Anti-Allergic Range
Our Pulmo Care portfolio is built on the foundation of therapeutic excellence, affordability, and patient-first innovation, ensuring better breathing and a better quality of life. QCL Lifescience is proud to be a trusted partner for healthcare providers in delivering comprehensive respiratory care solutions across all patient groups.

🔹 SFLO100, SFLO 200, SFLO-N Acebrophylline-based oral formulations used to treat and prevent symptoms of asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). These formulations help relax airway muscles, reduce inflammation, and improve airflow to the lungs—making breathing easier and more comfortable for patients.

🔹 QCHALER DPI DeviceAn innovative and user-friendly Dry Powder Inhaler, designed for accurate drug delivery and enhanced patient adherence—especially in long-term respiratory therapy.🔹 QCHALE-FB200, QCHALE-FB400Fixed-dose combinations of Formoterol and Budesonide that provide effective dual bronchodilation and anti-inflammatory action, ideal for managing persistent asthma and moderate to severe COPD.


Copyright © 2025 QCL - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.